What is the appropriate duration of antibiotic therapy for gram‑negative bacterial infections in adults?

Antibiotic Duration for Gram-Negative Bacterial Infections

For most uncomplicated gram-negative bacterial infections in adults, use 7 days of antibiotic therapy rather than the traditional 14 days.

Infection-Specific Recommendations

Community-Acquired Pneumonia (CAP)

• Prescribe antibiotics for a minimum of 5 days 1
• Extend beyond 5 days only if the patient has NOT achieved clinical stability, defined as:
  • Resolution of vital sign abnormalities
  • Ability to eat
  • Normal mentation
• Multiple RCTs including >8,400 patients demonstrate that 3-5 day courses are as effective as 5-14 day courses 2

Urinary Tract Infections

Uncomplicated cystitis (women):

• Nitrofurantoin: 5 days
• Trimethoprim-sulfamethoxazole: 3 days
• Fosfomycin: single dose 1

Uncomplicated pyelonephritis:

• Fluoroquinolones: 5-7 days
• Trimethoprim-sulfamethoxazole: 14 days (based on susceptibility) 1

Gram-Negative Bacteremia/Bloodstream Infections

This is where the most robust recent evidence exists:

• Use 7 days of antibiotics for uncomplicated gram-negative bacteremia 3, 4, 5
• The 2025 meta-analysis of 4 RCTs (3,729 patients) showed 7 days was noninferior to 14 days with 97.8% probability of noninferiority for 90-day mortality 3

Define "uncomplicated" as:

• Patient is afebrile and hemodynamically stable for ≥48 hours before discontinuation
• Adequate source control achieved
• No uncontrolled focus of infection
• Not severely immunocompromised 4, 5

For UTI-sourced gram-negative bacteremia specifically:

• 7 days is sufficient for most patients 6
• No significant differences in 30-day or 90-day mortality or recurrence rates between 7 and 14 days

Ventilator-Associated Pneumonia (VAP)

• Use 7-8 days rather than 10-15 days 2
• This applies even for non-fermenting gram-negative bacteria
• Durations shorter than 7 days have not been adequately studied

Key Clinical Pearls

Oral transition is appropriate: For uncomplicated gram-negative BSI, transition to oral antibiotics when clinically stable rather than continuing IV therapy through discharge 7, 8

No need for repeat blood cultures: In uncomplicated gram-negative bacteremia with clinical improvement, routine repeat blood cultures are not necessary 7

The evidence applies broadly across:

• All adult age groups (above and below 65 years)
• Both genders
• Various sources of infection (urinary and non-urinary)
• Immunocompetent and immunocompromised patients
• Patients with or without hypotension on initial presentation 4

Common Pitfalls to Avoid

1. Don't reflexively prescribe 14 days - This outdated practice increases antimicrobial resistance, adverse events (including C. difficile), and healthcare costs without improving outcomes

2. Don't confuse "uncomplicated" with "mild" - Patients can be quite ill initially but still qualify for short-course therapy if they achieve clinical stability by day 5-7

3. Don't continue IV antibiotics at discharge unnecessarily - Oral bioavailability of fluoroquinolones and trimethoprim-sulfamethoxazole is excellent for gram-negative infections

Strength of Evidence

The guideline recommendations 1 are reinforced by the highest quality recent evidence: a 2025 systematic review and meta-analysis of RCTs 3 showing clear noninferiority of 7-day courses. This represents Level 1 evidence with consistent findings across multiple large trials totaling thousands of patients. The 2023 individual patient data meta-analysis 4 further confirms these findings across diverse patient subgroups.